Home
CHUYÊN ĐỀ
Issue: Số 69 (2015)
Article
Phạm Mạnh Hùng: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Đinh Huỳnh Linh: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Published: April 1, 2015
Views: 111
References
1.
1. Stone, N. J., et al. (2014). “2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Circulation 129(25 Suppl 2): S1-45.
2.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation2002;106:3143–3421.
3.
3. American Heart Association. 2013 Prevention Guidelines Tools: CV Risk Calculator. Dallas, TX: American Heart Association; 2013
4.
4. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556–1565.
5.
5. Muntner P, Colantonio LD, Cushman M, et al. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. JAMA 2014;311:1406-15.
6.
6. American Association of Clinical Endocrinologists. Press Statement. Website: http://media.aace.com/ press-release/press-statement
7.
7. Leslie Cho, Chad Raymond et al. New cholesterol guidelines: Worth the wait? Cleveland Clinic Journal of MedicineJanuary 2014 vol. 81 1 11-19.